Ney Barbara, Lanzi Stefano, Calanca Luca, Mazzolai Lucia
Division of Angiology, Heart and Vessel Department, Lausanne University Hospital, 1011 Lausanne, Switzerland.
J Clin Med. 2021 May 11;10(10):2057. doi: 10.3390/jcm10102057.
This study aimed to evaluate the effect of a multimodal supervised exercise training (SET) program on walking performance for 12 months in patients with symptomatic lower extremity peripheral artery disease (PAD). Consecutive patients with Fontaine stage II PAD participating in the SET program of our hospital were retrospectively investigated. Walking performance, assessed using a treadmill with measures of the pain-free and maximal walking distance (PFWD, MWD, respectively), and 6 min walking distance (6MWD), were tested before and following SET, as well as at 6 and 12 months after SET completion. Ninety-three symptomatic patients with PAD (65.0 ± 1.1 y) were included in the study. Following SET, the walking performance significantly improved (PFWD: +145%, ≤ 0.001; MWD: +97%, ≤ 0.001; 6MWD: +15%, ≤ 0.001). At 6 months, PFWD (+257%, ≤ 0.001), MWD (+132%, ≤ 0.001), and 6MWD (+11%, ≤ 0.001) remained significantly improved compared with the pre-SET condition. At 12 months, PFWD (+272%, ≤ 0.001), MWD (+130%, ≤ 0.001), and 6MWD (+11%, ≤ 0.001) remained significantly improved compared with the pre-training condition. The walking performance remained significantly improved in both women and men for up to 12 months ( ≤ 0.001). Multimodal SET is effective at improving walking performance in symptomatic patients with PAD, with improvements lasting up to 12 months.
本研究旨在评估多模式监督运动训练(SET)计划对有症状的下肢外周动脉疾病(PAD)患者步行能力的影响,为期12个月。对我院参加SET计划的连续Fontaine II期PAD患者进行回顾性研究。在SET前后以及SET完成后的6个月和12个月,使用跑步机测量无痛步行距离(PFWD)、最大步行距离(MWD)和6分钟步行距离(6MWD)来评估步行能力。93例有症状的PAD患者(65.0±1.1岁)纳入本研究。SET后,步行能力显著改善(PFWD:增加145%,P≤0.001;MWD:增加97%,P≤0.001;6MWD:增加15%,P≤0.001)。在6个月时,与SET前相比,PFWD(增加257%,P≤0.001)、MWD(增加132%,P≤0.001)和6MWD(增加11%,P≤0.001)仍显著改善。在12个月时,与训练前相比,PFWD(增加272%,P≤0.001)、MWD(增加130%,P≤0.001)和6MWD(增加11%,P≤0.001)仍显著改善。男性和女性的步行能力在长达12个月内均保持显著改善(P≤0.001)。多模式SET对改善有症状的PAD患者的步行能力有效,且改善可持续长达12个月。